A fully human anti-IL-7Rα antibody promotes antitumor activity against T-cell acute lymphoblastic leukemia

T-cell acute lymphoblastic leukemia (T-ALL) is an aggressive hematological cancer for which treatment options often result in incomplete therapeutic efficacy and long-term side-effects. Interleukin 7 (IL-7) and its receptor IL-7Rα promote T-ALL development and mutational activation of IL-7Rα associa...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Leukemia
Main Authors: Akkapeddi, Padma, Fragoso, Rita, Hixon, Julie A., Ramalho, Ana Sofia, Oliveira, Mariana L., Carvalho, Tânia, Gloger, Andreas, Matasci, Mattia, Corzana, Francisco, Durum, Scott K., Neri, Dario, Bernardes, Gonçalo J. L., Barata, João T.
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group UK 2019
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6733707/
https://ncbi.nlm.nih.gov/pubmed/30850736
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41375-019-0434-8
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados